Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15569265rdf:typepubmed:Citationlld:pubmed
pubmed-article:15569265lifeskim:mentionsumls-concept:C0027882lld:lifeskim
pubmed-article:15569265lifeskim:mentionsumls-concept:C0162638lld:lifeskim
pubmed-article:15569265lifeskim:mentionsumls-concept:C0007765lld:lifeskim
pubmed-article:15569265lifeskim:mentionsumls-concept:C0010837lld:lifeskim
pubmed-article:15569265lifeskim:mentionsumls-concept:C0026187lld:lifeskim
pubmed-article:15569265lifeskim:mentionsumls-concept:C1366876lld:lifeskim
pubmed-article:15569265lifeskim:mentionsumls-concept:C1833235lld:lifeskim
pubmed-article:15569265lifeskim:mentionsumls-concept:C1704259lld:lifeskim
pubmed-article:15569265lifeskim:mentionsumls-concept:C0443199lld:lifeskim
pubmed-article:15569265lifeskim:mentionsumls-concept:C1705987lld:lifeskim
pubmed-article:15569265lifeskim:mentionsumls-concept:C0851285lld:lifeskim
pubmed-article:15569265lifeskim:mentionsumls-concept:C1292733lld:lifeskim
pubmed-article:15569265pubmed:issue5lld:pubmed
pubmed-article:15569265pubmed:dateCreated2004-11-30lld:pubmed
pubmed-article:15569265pubmed:abstractTextMinocycline has been shown to have remarkably neuroprotective qualities, but underlying mechanisms remain elusive. We reported here the robust neuroprotection by minocycline against glutamate-induced apoptosis through regulations of p38 and Akt pathways. Pre-treatment of cerebellar granule neurons (CGNs) with minocycline (10-100 microm) elicited a dose-dependent reduction of glutamate excitotoxicity and blocked glutamate-induced nuclear condensation and DNA fragmentations. Using patch-clamping and fluorescence Ca2+ imaging techniques, it was found that minocycline neither blocked NMDA receptors, nor reduced glutamate-caused rises in intracellular Ca2+. Instead, confirmed by immunoblots, minocycline in vivo and in vitro was shown to directly inhibit the activation of p38 caused by glutamate. A p38-specific inhibitor, SB203580, also attenuated glutamate excitotoxicity. Furthermore, the neuroprotective effects of minocycline were blocked by phosphatidylinositol 3-kinase (PI3-K) inhibitors LY294002 and wortmannin, while pharmacologic inhibition of glycogen synthase kinase 3beta (GSK3beta) attenuated glutamate-induced apoptosis. In addition, immunoblots revealed that minocycline reversed the suppression of phosphorylated Akt and GSK3beta caused by glutamate, as were abolished by PI3-K inhibitors. These results demonstrate that minocycline prevents glutamate-induced apoptosis in CGNs by directly inhibiting p38 activity and maintaining the activation of PI3-K/Akt pathway, which offers a novel modality as to how the drug exerts protective effects.lld:pubmed
pubmed-article:15569265pubmed:languageenglld:pubmed
pubmed-article:15569265pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15569265pubmed:citationSubsetIMlld:pubmed
pubmed-article:15569265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15569265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15569265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15569265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15569265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15569265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15569265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15569265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15569265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15569265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15569265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15569265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15569265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15569265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15569265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15569265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15569265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15569265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15569265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15569265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15569265pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15569265pubmed:statusMEDLINElld:pubmed
pubmed-article:15569265pubmed:monthDeclld:pubmed
pubmed-article:15569265pubmed:issn0022-3042lld:pubmed
pubmed-article:15569265pubmed:authorpubmed-author:SucherNikolau...lld:pubmed
pubmed-article:15569265pubmed:authorpubmed-author:PuYongmeiYlld:pubmed
pubmed-article:15569265pubmed:authorpubmed-author:ChangDonald...lld:pubmed
pubmed-article:15569265pubmed:authorpubmed-author:ChanLing...lld:pubmed
pubmed-article:15569265pubmed:authorpubmed-author:LiMingtaoMlld:pubmed
pubmed-article:15569265pubmed:authorpubmed-author:LiWenmingWlld:pubmed
pubmed-article:15569265pubmed:authorpubmed-author:HanYifanYlld:pubmed
pubmed-article:15569265pubmed:authorpubmed-author:PiRongbiaoRlld:pubmed
pubmed-article:15569265pubmed:authorpubmed-author:LeeNelson T...lld:pubmed
pubmed-article:15569265pubmed:authorpubmed-author:ChanHugh H...lld:pubmed
pubmed-article:15569265pubmed:issnTypePrintlld:pubmed
pubmed-article:15569265pubmed:volume91lld:pubmed
pubmed-article:15569265pubmed:ownerNLMlld:pubmed
pubmed-article:15569265pubmed:authorsCompleteYlld:pubmed
pubmed-article:15569265pubmed:pagination1219-30lld:pubmed
pubmed-article:15569265pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:15569265pubmed:meshHeadingpubmed-meshheading:15569265...lld:pubmed
pubmed-article:15569265pubmed:meshHeadingpubmed-meshheading:15569265...lld:pubmed
pubmed-article:15569265pubmed:meshHeadingpubmed-meshheading:15569265...lld:pubmed
pubmed-article:15569265pubmed:meshHeadingpubmed-meshheading:15569265...lld:pubmed
pubmed-article:15569265pubmed:meshHeadingpubmed-meshheading:15569265...lld:pubmed
pubmed-article:15569265pubmed:meshHeadingpubmed-meshheading:15569265...lld:pubmed
pubmed-article:15569265pubmed:meshHeadingpubmed-meshheading:15569265...lld:pubmed
pubmed-article:15569265pubmed:meshHeadingpubmed-meshheading:15569265...lld:pubmed
pubmed-article:15569265pubmed:meshHeadingpubmed-meshheading:15569265...lld:pubmed
pubmed-article:15569265pubmed:meshHeadingpubmed-meshheading:15569265...lld:pubmed
pubmed-article:15569265pubmed:meshHeadingpubmed-meshheading:15569265...lld:pubmed
pubmed-article:15569265pubmed:meshHeadingpubmed-meshheading:15569265...lld:pubmed
pubmed-article:15569265pubmed:meshHeadingpubmed-meshheading:15569265...lld:pubmed
pubmed-article:15569265pubmed:meshHeadingpubmed-meshheading:15569265...lld:pubmed
pubmed-article:15569265pubmed:meshHeadingpubmed-meshheading:15569265...lld:pubmed
pubmed-article:15569265pubmed:meshHeadingpubmed-meshheading:15569265...lld:pubmed
pubmed-article:15569265pubmed:meshHeadingpubmed-meshheading:15569265...lld:pubmed
pubmed-article:15569265pubmed:meshHeadingpubmed-meshheading:15569265...lld:pubmed
pubmed-article:15569265pubmed:meshHeadingpubmed-meshheading:15569265...lld:pubmed
pubmed-article:15569265pubmed:meshHeadingpubmed-meshheading:15569265...lld:pubmed
pubmed-article:15569265pubmed:meshHeadingpubmed-meshheading:15569265...lld:pubmed
pubmed-article:15569265pubmed:meshHeadingpubmed-meshheading:15569265...lld:pubmed
pubmed-article:15569265pubmed:meshHeadingpubmed-meshheading:15569265...lld:pubmed
pubmed-article:15569265pubmed:meshHeadingpubmed-meshheading:15569265...lld:pubmed
pubmed-article:15569265pubmed:meshHeadingpubmed-meshheading:15569265...lld:pubmed
pubmed-article:15569265pubmed:meshHeadingpubmed-meshheading:15569265...lld:pubmed
pubmed-article:15569265pubmed:meshHeadingpubmed-meshheading:15569265...lld:pubmed
pubmed-article:15569265pubmed:meshHeadingpubmed-meshheading:15569265...lld:pubmed
pubmed-article:15569265pubmed:meshHeadingpubmed-meshheading:15569265...lld:pubmed
pubmed-article:15569265pubmed:meshHeadingpubmed-meshheading:15569265...lld:pubmed
pubmed-article:15569265pubmed:meshHeadingpubmed-meshheading:15569265...lld:pubmed
pubmed-article:15569265pubmed:meshHeadingpubmed-meshheading:15569265...lld:pubmed
pubmed-article:15569265pubmed:meshHeadingpubmed-meshheading:15569265...lld:pubmed
pubmed-article:15569265pubmed:meshHeadingpubmed-meshheading:15569265...lld:pubmed
pubmed-article:15569265pubmed:meshHeadingpubmed-meshheading:15569265...lld:pubmed
pubmed-article:15569265pubmed:meshHeadingpubmed-meshheading:15569265...lld:pubmed
pubmed-article:15569265pubmed:meshHeadingpubmed-meshheading:15569265...lld:pubmed
pubmed-article:15569265pubmed:meshHeadingpubmed-meshheading:15569265...lld:pubmed
pubmed-article:15569265pubmed:year2004lld:pubmed
pubmed-article:15569265pubmed:articleTitleMinocycline prevents glutamate-induced apoptosis of cerebellar granule neurons by differential regulation of p38 and Akt pathways.lld:pubmed
pubmed-article:15569265pubmed:affiliationDepartment of Biochemistry, Hong Kong University of Science & Technology, Clear Water Bay, Kowloon, Hong Kong, China.lld:pubmed
More...